Okklo Life Sciences

Company
Technology
Programs
Partnering
News
Contact
- Where to meet us
- Disclaimer

Via our unique expertise and network we can design novel cyclodextrins for a wide variety of therapeutic areas

Our vision is to be the leading biotech providing cyclodextrin-based therapeutics to improve the life of patients.

Okklo Life Sciences: custom design and development of therapeutic cyclodextrins

Okklo Life Sciences

Novel therapeutic solutions using cyclodextrin-based technologies

Drug Discovery Today

How are laboratories tackling misinformation? 09/15/2022
Lithuania to host one of the most important biotechnology events in Europe: EFIB’22 09/09/2022
Lonza and Touchlight collaborate on end-to-end mRNA offering 09/08/2022
Salipro Biotech Obtains Granted Patents in the United States and China for Direct Extraction of Membrane Proteins and Library Generation 09/08/2022
A More Connected Future for Pharma 08/31/2022

Follow us on:

Recent Okklo News

Okklo’s hematology asset will be further developed by Alveron Pharma 05/16/2019
Okklo and SolAeroMed partner to develop cyclodextrins for cystic fibrosis treatment 06/27/2017
Okklo Life Sciences B.V. and Sanquin sign commercialization agreement to enter IND enabling studies and clinical development. 01/10/2017
Okklo receives RedMedTech Ventures funding and extends collaboration with Sanquin 05/15/2016

Company
Technology
Programs
Partnering
News
Contact

Copyright © 2016 | Okklo Life Sciences | All Rights Reserved